← Evidence map

ArticleCase reports in oncology

Gemcitabine, Cisplatin, and Durvalumab for Alpha-Fetoprotein-Producing Cancer of Unknown Primary Suspected from the Biliary Tract: A Case Report.

Kei Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Gemcitabine, Cisplatin, and Durvalumab for Alpha-Fetoprotein-Producing Cancer of Unknown Primary Suspected from the Biliary Tract: A Case Report. | OpenQuestion